首页 | 本学科首页   官方微博 | 高级检索  
检索        

吉非替尼联合放疗在高龄中晚期肺癌患者治疗中疗效分析
引用本文:郑日葵.吉非替尼联合放疗在高龄中晚期肺癌患者治疗中疗效分析[J].中国现代医生,2011,49(14):152-153.
作者姓名:郑日葵
作者单位:浙江省义乌市第三人民医院肿瘤内科,浙江义乌,322000
摘    要:目的探讨吉非替尼联合放疗治疗高龄肺癌患者的疗效。方法诊断明确的61例高龄中晚期肺癌患者按治疗方法分为两组:对照组30例为放射治疗组,治疗组31例在放射治疗的基础上,从治疗第1天开始口服吉非替尼,每日250mg,直至病变进展或其他原因停药。结果治疗组总控制率为93.55%,对照组为70.00%,两组相比有显著性差异(P〈0.05)。结论吉非替尼联合放疗治疗高龄肺癌具有较好的近期疗效,值得进一步研究。

关 键 词:吉非替尼  放射疗法  肺癌

Clinical Efficacy of Gefitinib Combined with Radiotherapy for Senile Patients with Lung Cancer
Authors:Zheng Rikui
Institution:Zheng Rikui Department of Oncology,the Third People's Hospital of Yiwu in Zhejiang Province,Yiwu 322000,China
Abstract:Objective To study the clinical efficacy of gefitinib combined with radiotherapy for senile patients with lung cancer.Methods Sixty-one patients diagnosed as medium-advanced lung cancer were devided into treatment group and control group according to their treatment methods:30 cases in control group received radiotherapy,and 31 cases in treatment group orally received gefitinib 250mg daily on the basis of radiotherapy until disease progression or withdrawal for other reasons.Results The total control rate o...
Keywords:Gefitinib  Radiotherapy  Lung cancer  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号